Search Results - "Treloar, C"

The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes by Lancaster, K., Seear, K., Treloar, C., Ritter, A.

“…For over twenty years there have been calls for greater ‘consumer’ participation in health decision-making. While it is recognised by governments and other…”
Get full text

The impact of sources of stigma on health care avoidance among gay and bisexual men in Australia by Brener, L., Broady, T., Cama, E., Treloar, C.

“…Stigma has a negative impact on health and wellbeing for gay and bisexual men (GBM). There is little research which assesses whether stigma from various…”
Get full text

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience by Marshall, A.D., Grebely, J., Dore, G.J., Treloar, C.

“…•Overall, participants found engagement in hepatitis C care a rewarding experience.•Practitioners require further hepatitis C testing and liver disease staging…”
Get full text

Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals by Treloar, C., Newland, J., Rance, J., Hopwood, M.

“…Uptake of treatment for hepatitis C virus (HCV) infection is very low particularly among people who have injected drugs. Opiate substitution treatment (OST)…”
Get full text

The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs by Rance, J., Grebely, J., Treloar, C.

“…Australia has made considerable progress towards the public-health 'elimination' of the hepatitis C virus. Nonetheless, reinfection remains a key challenge,…”
Get full text

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study by Treloar, C., Rance, J., Dore, G. J., Grebely, J.

“…Summary Provision of hepatitis C virus (HCV) assessment and treatment via opioid substitution treatment (OST) clinics has been posed as an effective means of…”
Get full text

‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective by Marshall, AD, Rance, J, Grebely, J, Treloar, C

“…To achieve hepatitis C viral (HCV) elimination targets set by the World Health Organisation, pillars of the HCV care cascade are often referenced to track…”
Get full text

Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence by Lancaster, K., Gendera, S., Treloar, C., Rhodes, T., Shahbazi, J., Byrne, M., Nielsen, S., Degenhardt, L., Farrell, M.

“…We examine how extended-release buprenorphine depot (BUP-XR) is put to use and made to work in implementation practices, attending to how care practices are…”
Get full text

“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting by Lafferty, L., Rance, J., Byrne, M., Milat, A., Dore, G.J., Grebely, J., Lloyd, A.R., Treloar, C.

“…Hepatitis C (HCV) is highly prevalent among people who are incarcerated. HCV treatment-as-prevention was implemented in the SToP-C trial in four correctional…”
Get full text

Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs by Brener, L., Caruana, T., Broady, T., Cama, E., Ezard, N., Madden, A., Treloar, C.

“…•Compares a sample injecting opioids and stimulants to people injecting an opioid or stimulant only.•People who inject both opioids and stimulants experience…”
Get full text

Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel by Lafferty, L., Rance, J., Dore, G.J., Grebely, J., Lloyd, A.R., Treloar, C.

“…Hepatitis C (HCV) infection is prevalent in the prison setting, with sharing of unsterile injecting equipment the most common mode of transmission in high…”
Get full text

Understanding decisions made about hepatitis C treatment by couples who inject drugs by Treloar, C., Rance, J., Bryant, J., Fraser, S.

“…Summary Efforts to increase the number of people having hepatitis C virus (HCV) treatment require understanding how to best deliver services to meet consumers'…”
Get full text

Trust and service engagement among people who inject drugs after release from prison by Lafferty, L., Schroeder, S., Marshall, A.D., Drysdale, K., Higgs, P., Stoové, M., Baldry, E., Dietze, P., Treloar, C.

“…•Trust influences service engagement, and can influence post-release experiences.•Service provider competence impacts on notions of trust, and can influence…”
Get full text

Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison by Lafferty, L., Treloar, C., Guthrie, J., Chambers, G. M., Butler, T.

“…Summary Prisoner populations are characterized by high rates of hepatitis C (HCV), up to thirty times that of the general population in Australia. Within…”
Get full text

'Our culture makes us strong': Understanding and working with community strengths among Aboriginal people in western Sydney by Gardner, K, Graham, S, Beadman, M, Doyle, M, Wilms, J, Beetson, K, Bryant, J, Martin, K, Treloar, C, Murphy, D, Bell, S, Browne, A, Aggleton, P, Bolt, R

“…Strengths-based approaches to health care are often seen as an alternative to deficit-based approaches and are common in Aboriginal health settings. Despite…”
Get full text

A Proposed Exogenous Cause of the Global Temperature Hiatus by Norman C. Treloar

“…Since 1850, the rise in global mean surface temperatures (GMSTs) from increasing atmospheric concentrations of greenhouse gases (GHGs) has exhibited three…”
Get full text

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study by Conway, A., Valerio, H., Peacock, A., Degenhardt, L., Hayllar, J., Harrod, ME, Henderson, C., Read, P., Gilliver, R., Christmass, M., Dunlop, A., Montebello, M., Whitton, G., Reid, D., Lam, T., Alavi, M., Silk, D., Marshall, AD, Treloar, C., Dore, GJ, Grebely, J.

“…•Recent benzodiazepine and hazardous alcohol use is associated with opioid overdose.•Naloxone coverage is low among people at risk of overdose.•Two thirds of…”
Get full text

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia by Grebely, J., Bryant, J., Hull, P., Hopwood, M., Lavis, Y., Dore, G. J., Treloar, C.

“…Assessment and treatment for hepatitis C virus (HCV) in the community remains low. We evaluated factors associated with HCV specialist assessment and treatment…”
Get full text

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study by Marshall, A.D, Micallef, M, Erratt, A, Telenta, J, Treloar, C, Everingham, H, Jones, S.C, Bath, N, How-Chow, D, Byrne, J, Harvey, P, Dunlop, A, Jauncey, M, Read, P, Collie, T, Dore, G.J, Grebely, J

“…Highlights • PWID had moderate levels of HCV and liver disease knowledge. • PWID stated high willingness to receive HCV treatment. • Frequency of injection…”
Get full text

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study by Alavi, M., Micallef, M., Fortier, E., Dunlop, A. J., Balcomb, A. C., Day, C. A., Treloar, C., Bath, N., Haber, P. S., Dore, G. J., Grebely, J.

“…Summary Among people who inject drugs (PWID) with chronic HCV, the association between HCV treatment willingness and intent, and HCV specialist assessment and…”
Get full text